BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹317 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr | ₹238 Cr |
What is the latest Total Liabilities ratio of BAL PHARMA ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹317 Cr |
Mar2023 | ₹311 Cr |
Mar2022 | ₹261 Cr |
Mar2021 | ₹240 Cr |
Mar2020 | ₹238 Cr |
How is Total Liabilities of BAL PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹317 Cr | 1.96 | |
Mar2023 | ₹311 Cr | 19.37 | |
Mar2022 | ₹261 Cr | 8.52 | |
Mar2021 | ₹240 Cr | 0.71 | |
Mar2020 | ₹238 Cr | - |
Compare Total Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹135.7 Cr | -5.1% | -12.4% | -27.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -5.1% |
-12.4% |
-27.5% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses